Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum.

Application of continuous vacuum pressure on skin perforated with tiny micropores created by a focused beam from a low-cost laser system can result in access to a clear, transdermal body fluid (TDF) for the continuous measurement of glucose in vivo. Two clinical studies were performed to assess the feasibility of this approach. In the first study, 56 diabetic subjects were porated on either the arm or abdomen, and glucose was measured in their TDF using a custom assay system contained in a patch that was affixed to the skin above the poration site. The continuous readings of glucose in TDF were compared with fingerstick blood measured every half-hour over a 2-day period, resulting in 1,167 paired data points that yielded a correlation of 0.8745 with 97.75% of the readings in the Clarke Error Grid A and B zones. In a second study, 187 diabetic and 65 nondiabetic subjects had glucose measurements from their TDF made using a commercially available glucose strip and meter. A total of 4,059 data pairs (discrete TDF and capillary blood) were collected over a 2-day period, resulting in a correlation of 0.946 with 99% of the readings in the Clarke Error Grid A and B zones. These studies indicate that TDF drawn through micropores in the stratum corneum of the skin potentially can provide a lesser invasive and continuous method of measuring glucose in diabetic individuals.

[1]  A Smith,et al.  Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. , 1999, Diabetes technology & therapeutics.

[2]  John M Ellison,et al.  Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. , 2002, Diabetes care.

[3]  K. Jungheim,et al.  Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. , 2002, Diabetes care.

[4]  R O Potts,et al.  Detection of hypoglycemia with the GlucoWatch biographer. , 2001, Diabetes care.

[5]  Peter C O'Brien,et al.  Dermal Interstitial Glucose as an Indicator of Ambient Glycemia , 1997, Diabetes Care.

[6]  F. Reman,et al.  The determination of lipids and proteins in suction blister fluid. , 1979, The Journal of investigative dermatology.

[7]  M. Shults,et al.  A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.

[8]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[9]  J. Mastrototaro,et al.  The MiniMed continuous glucose monitoring system. , 2000, Diabetes technology & therapeutics.

[10]  M Gerritsen,et al.  Problems associated with subcutaneously implanted glucose sensors. , 2000, Diabetes care.

[11]  W Thomas,et al.  Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. , 1997, The Journal of laboratory and clinical medicine.

[12]  David C. Klonoff,et al.  Noninvasive Blood Glucose Monitoring , 1997, Diabetes Care.

[13]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.